CN103965302A - 一种重组超抗原seb突变体,其制备方法及应用 - Google Patents
一种重组超抗原seb突变体,其制备方法及应用 Download PDFInfo
- Publication number
- CN103965302A CN103965302A CN201310031999.1A CN201310031999A CN103965302A CN 103965302 A CN103965302 A CN 103965302A CN 201310031999 A CN201310031999 A CN 201310031999A CN 103965302 A CN103965302 A CN 103965302A
- Authority
- CN
- China
- Prior art keywords
- seb
- mutant
- superantigen
- sequence
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310031999.1A CN103965302B (zh) | 2013-01-29 | 2013-01-29 | 一种重组超抗原seb突变体,其制备方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310031999.1A CN103965302B (zh) | 2013-01-29 | 2013-01-29 | 一种重组超抗原seb突变体,其制备方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103965302A true CN103965302A (zh) | 2014-08-06 |
CN103965302B CN103965302B (zh) | 2019-05-28 |
Family
ID=51235348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310031999.1A Active CN103965302B (zh) | 2013-01-29 | 2013-01-29 | 一种重组超抗原seb突变体,其制备方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103965302B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107312781A (zh) * | 2017-08-31 | 2017-11-03 | 曾庆明 | 重组金黄色葡萄球菌b型肠毒素蛋白及其制备方法与应用 |
CN115427433A (zh) * | 2020-12-18 | 2022-12-02 | 生物医学研究及生物制品公司 | 保护性葡萄球菌外毒素疫苗 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5601830A (en) * | 1995-03-31 | 1997-02-11 | Wisconsin Alumni Research Foundation | Staphylococcus aureus enterotoxin H and methods of use |
CN1332804A (zh) * | 1998-06-24 | 2002-01-23 | 病毒科学公司 | 监控核苷类逆转录酶抑制剂抗逆转录病毒治疗和在治疗hiv/aids中指导治疗决定的途径与方法 |
CN1522156A (zh) * | 2001-06-28 | 2004-08-18 | ��Ծ���\������˾ | 用于人类治疗的新的工程化超抗原 |
EP1980254A1 (en) * | 2007-04-13 | 2008-10-15 | Rijksuniversiteit te Groningen | Means and methods for counteracting protein aggregation |
CN102516392A (zh) * | 2011-11-25 | 2012-06-27 | 孙嘉琳 | 一种癌靶向超抗原融合蛋白及制备方法及用途 |
-
2013
- 2013-01-29 CN CN201310031999.1A patent/CN103965302B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5601830A (en) * | 1995-03-31 | 1997-02-11 | Wisconsin Alumni Research Foundation | Staphylococcus aureus enterotoxin H and methods of use |
CN1332804A (zh) * | 1998-06-24 | 2002-01-23 | 病毒科学公司 | 监控核苷类逆转录酶抑制剂抗逆转录病毒治疗和在治疗hiv/aids中指导治疗决定的途径与方法 |
CN1522156A (zh) * | 2001-06-28 | 2004-08-18 | ��Ծ���\������˾ | 用于人类治疗的新的工程化超抗原 |
EP1980254A1 (en) * | 2007-04-13 | 2008-10-15 | Rijksuniversiteit te Groningen | Means and methods for counteracting protein aggregation |
CN102516392A (zh) * | 2011-11-25 | 2012-06-27 | 孙嘉琳 | 一种癌靶向超抗原融合蛋白及制备方法及用途 |
Non-Patent Citations (2)
Title |
---|
PURSCHKE WG 等: "A DNA Spiegelmer to staphylococcal enterotoxin B", 《NUCLEIC ACIDS RES》 * |
郑欣 等: "葡萄球菌肠毒素B突变体的构建及其抗肿瘤活性分析", 《生物技术通讯》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107312781A (zh) * | 2017-08-31 | 2017-11-03 | 曾庆明 | 重组金黄色葡萄球菌b型肠毒素蛋白及其制备方法与应用 |
CN107312781B (zh) * | 2017-08-31 | 2020-04-21 | 曾庆明 | 重组金黄色葡萄球菌b型肠毒素蛋白及其制备方法与应用 |
CN115427433A (zh) * | 2020-12-18 | 2022-12-02 | 生物医学研究及生物制品公司 | 保护性葡萄球菌外毒素疫苗 |
Also Published As
Publication number | Publication date |
---|---|
CN103965302B (zh) | 2019-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106191062B (zh) | 一种tcr-/pd-1-双阴性t细胞及其构建方法 | |
Denies et al. | Combination of interleukin-12 gene therapy, metronomic cyclophosphamide and DNA cancer vaccination directs all arms of the immune system towards tumor eradication | |
CN103113470A (zh) | 靶向人egfr的基因工程化淋巴细胞及其制备方法和用途 | |
CN108484776B (zh) | 一种融合蛋白、制备方法及其应用 | |
Yuan et al. | Interleukin-7 enhances the in vivo anti-tumor activity of tumor-reactive CD8+ T cells with induction of IFN-gamma in a murine breast cancer model | |
CN102199218A (zh) | 一种抗Her2抗体-白细胞介素2融合蛋白及其用途 | |
Burrack et al. | CD40 agonist overcomes T cell exhaustion induced by chronic myeloid cell IL-27 production in a pancreatic cancer preclinical model | |
Domínguez‐Romero et al. | Generation of multiepitope cancer vaccines based on large combinatorial libraries of survivin‐derived mutant epitopes | |
CN106589131A (zh) | 融合蛋白4D5Fv-PE25及其制备方法和用途 | |
US20040001852A1 (en) | Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses | |
CN103965302A (zh) | 一种重组超抗原seb突变体,其制备方法及应用 | |
CN102775494A (zh) | 一种抗cd3/抗cd133双特异性抗体及该双抗装载的cik细胞 | |
CN101486758B (zh) | mda-7/IL-24突变体多肽及其制备方法及用途 | |
CN101061136B (zh) | 具有白介素-2中和能力的免疫治疗制剂 | |
CN103360497A (zh) | 一种新型抗肿瘤融合蛋白疫苗及其制备方法和应用 | |
CN102516392A (zh) | 一种癌靶向超抗原融合蛋白及制备方法及用途 | |
EP2729166B1 (en) | Cancer antigen | |
CN102838679B (zh) | Her2‑neu抗原阳性肿瘤治疗性疫苗的制备及应用 | |
CN102153632A (zh) | 抗大肠杆菌TolC二十三肽的抗体及应用 | |
CN104127871A (zh) | Cxcl4单抗治疗肿瘤及化疗后肿瘤加速再增殖基因筛选法 | |
CN106806890A (zh) | 重组人vegf多肽肿瘤疫苗 | |
CN103897067B (zh) | 一种治疗肿瘤的重组多肽 | |
CN100444895C (zh) | 用于恶性肿瘤治疗的免疫调节制剂 | |
CN102336835A (zh) | 白细胞介素3衍生片段的融合蛋白及其用途 | |
CN113754756B (zh) | 一种识别hla-a*02:01/e629-38的tcr及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
DD01 | Delivery of document by public notice |
Addressee: Wang Zhongze Document name: Notification of Passing Examination on Formalities |
|
DD01 | Delivery of document by public notice | ||
CB02 | Change of applicant information |
Address after: 100071 Beijing Fengtai District, East Street, No. 20, Five Rooms and One Room Applicant after: Institute of Microbial Epidemiology, Military Medical Research Institute, Academy of Military Sciences Address before: 100071 No. 20 East Main Street, Beijing, Fengtai District Applicant before: Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, PR China |
|
CB02 | Change of applicant information | ||
CB03 | Change of inventor or designer information |
Inventor after: Zheng Yuling Inventor after: Jiang Hua Inventor after: Jiang Yongqiang Inventor after: Gu Liwei Inventor after: Zheng Xin Inventor after: Wang Jun Inventor after: Wang Yanzi Inventor before: Jiang Yongqiang Inventor before: Jiang Hua Inventor before: Zheng Yuling Inventor before: Gu Liwei Inventor before: Zheng Xin Inventor before: Wang Jun Inventor before: Wang Yanzi |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |